Search
for

    Research

    5 / 1000+ results

      research A novel actor in skin biology: the mineralocorticoid receptor

      7 citations , October 2015 in “Experimental dermatology”
      This study found that topical MR blockers alongside glucocorticoids may limit glucocorticoid-induced skin atrophy, suggesting MR's significant role in skin-related endocrinology.

      research Scalp Psoriasis

      July 2018 in “Elsevier eBooks”
      This review discusses the diagnosis of alopecia in psoriasis, highlighting different hair loss types and the need to distinguish it from similar conditions, but reports no new clinical results.

      research Drug Repurposing in Dermatology: Molecular Biology and Omics Approach

      1 citations , August 2020 in “IntechOpen eBooks”
      This review highlights drug repositioning strategies for discovering new treatments for skin conditions and reports no new clinical results, emphasizing the integration of systematic methods with advances in molecular biology and omics.

      research Androgen excess: Investigations and management

      82 citations , May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      This article outlines the clinical features, evaluation, and treatment strategies for androgen excess in polycystic ovary syndrome, highlighting important diagnostic and management approaches but reporting no new research results.

    Community Join

    5 / 1000+ results

      community Are there ever going to be any oral DHT blocking treatments in the future?

       5 upvotes 2 years ago
      The discussion revolves around the need for future oral DHT blockers for hair loss treatment that don't have the side effects of current options like Finasteride and Dutasteride. One user suggests that the future of hair loss treatment will likely be topical anti-androgens, as they can target hair follicles without affecting the entire system.

      community The Cure isn't 5 years away; it's already here.

      in Research/Science  1005 upvotes 1 year ago
      PP405 is a new topical treatment for hair loss, showing promise in trials but still requires finasteride for maintenance. There is skepticism about its effectiveness and safety, with concerns about needing finasteride to maintain results.

      community 2 years on treatment (stack update)

       465 upvotes 1 year ago
      A user shared their hair regrowth progress using Dutasteride, topical Minoxidil, Spironolactone, and Estradiol Valerate injections as part of hormone replacement therapy for transitioning. They experienced significant hair improvement and personal satisfaction but caution against this approach for non-transitioning individuals due to irreversible changes.

      community Finasteride to Dutasteride 6 months teenager 17M AMA

       312 upvotes 1 year ago
      A 17-year-old is using oral dutasteride, finasteride, and topical minoxidil for hair loss, with plans to increase dutasteride and consider surgery. They report significant regrowth but are worried about side effects and the effects of blocking DHT at a young age.